158 related articles for article (PubMed ID: 38561668)
1. Negative regulation of thyroid adenoma-associated protein (THADA) in the cardiac glycoside-induced anti-cancer effect.
Katoh M; Fujii T; Tabuchi Y; Shimizu T; Sakai H
J Physiol Sci; 2024 Apr; 74(1):23. PubMed ID: 38561668
[TBL] [Abstract][Full Text] [Related]
2. Cardiac glycosides stimulate endocytosis of GLUT1 via intracellular Na
Fujii T; Katoh M; Ootsubo M; Nguyen OTT; Iguchi M; Shimizu T; Tabuchi Y; Shimizu Y; Takeshima H; Sakai H
J Cell Physiol; 2022 Jul; 237(7):2980-2991. PubMed ID: 35511727
[TBL] [Abstract][Full Text] [Related]
3. Cardiac glycosides induced toxicity in human cells expressing α1-, α2-, or α3-isoforms of Na-K-ATPase.
Cherniavsky Lev M; Karlish SJ; Garty H
Am J Physiol Cell Physiol; 2015 Jul; 309(2):C126-35. PubMed ID: 25994790
[TBL] [Abstract][Full Text] [Related]
4. Cross-resistance and biochemical studies with two classes of HeLa cell mutants resistant to cardiac glycosides. The unusual behavior of cardenolide SC4453.
Gupta RS; Chopra A
J Biol Chem; 1985 Jun; 260(11):6843-50. PubMed ID: 2987235
[TBL] [Abstract][Full Text] [Related]
5. Cardiac glycoside activities link Na(+)/K(+) ATPase ion-transport to breast cancer cell migration via correlative SAR.
Magpusao AN; Omolloh G; Johnson J; Gascón J; Peczuh MW; Fenteany G
ACS Chem Biol; 2015 Feb; 10(2):561-9. PubMed ID: 25334087
[TBL] [Abstract][Full Text] [Related]
6. Biochemical and cross-resistance studies with HeLa cell mutants resistant to cardiac glycoside SC4453. Regulation of the resistant form of Na+/K+-ATPase in the mutant cells.
Chopra A; Gupta RS
J Biol Chem; 1986 Feb; 261(5):2034-40. PubMed ID: 3003091
[TBL] [Abstract][Full Text] [Related]
7. Crosstalk between Na
Fujii T; Shimizu T; Yamamoto S; Funayama K; Fujita K; Tabuchi Y; Ikari A; Takeshima H; Sakai H
Biochim Biophys Acta Mol Basis Dis; 2018 Nov; 1864(11):3792-3804. PubMed ID: 30251696
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the Na
Shandell MA; Capatina AL; Lawrence SM; Brackenbury WJ; Lagos D
J Biol Chem; 2022 Mar; 298(3):101707. PubMed ID: 35150740
[TBL] [Abstract][Full Text] [Related]
9. [Cancer cell-specific functional relation between Na
Fujii T; Shimizu T; Takeshima H; Sakai H
Nihon Yakurigaku Zasshi; 2019; 154(3):103-107. PubMed ID: 31527358
[TBL] [Abstract][Full Text] [Related]
10. Ouabain interactions with the H5-H6 hairpin of the Na,K-ATPase reveal a possible inhibition mechanism via the cation binding domain.
Palasis M; Kuntzweiler TA; Argüello JM; Lingrel JB
J Biol Chem; 1996 Jun; 271(24):14176-82. PubMed ID: 8662895
[TBL] [Abstract][Full Text] [Related]
11. Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.
Hauck C; Potter T; Bartz M; Wittwer T; Wahlers T; Mehlhorn U; Scheiner-Bobis G; McDonough AA; Bloch W; Schwinger RH; Müller-Ehmsen J
Eur J Pharmacol; 2009 Nov; 622(1-3):7-14. PubMed ID: 19751721
[TBL] [Abstract][Full Text] [Related]
12. Determinants of human and mouse melanoma cell sensitivities to oleandrin.
Lin Y; Dubinsky WP; Ho DH; Felix E; Newman RA
J Exp Ther Oncol; 2008; 7(3):195-205. PubMed ID: 19066128
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of peripheral blood mononuclear cell proliferation by cardiac glycosides.
Gentile DA; Henry J; Katz AJ; Skoner DP
Ann Allergy Asthma Immunol; 1997 May; 78(5):466-72. PubMed ID: 9164359
[TBL] [Abstract][Full Text] [Related]
14. Physiological role of the alpha1- and alpha2-isoforms of the Na+-K+-ATPase and biological significance of their cardiac glycoside binding site.
Dostanic-Larson I; Lorenz JN; Van Huysse JW; Neumann JC; Moseley AE; Lingrel JB
Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R524-8. PubMed ID: 16467499
[TBL] [Abstract][Full Text] [Related]
15. Endogenous and exogenous cardiac glycosides: their roles in hypertension, salt metabolism, and cell growth.
Schoner W; Scheiner-Bobis G
Am J Physiol Cell Physiol; 2007 Aug; 293(2):C509-36. PubMed ID: 17494630
[TBL] [Abstract][Full Text] [Related]
16. Identification of an amino acid substitution in human alpha 1 Na,K-ATPase which confers differentially reduced affinity for two related cardiac glycosides.
Askew GR; Lingrel JB
J Biol Chem; 1994 Sep; 269(39):24120-6. PubMed ID: 7929066
[TBL] [Abstract][Full Text] [Related]
17. Retinoschisin and Cardiac Glycoside Crosstalk at the Retinal Na/K-ATPase.
Schmid V; Plössl K; Schmid C; Bernklau S; Weber BHF; Friedrich U
Invest Ophthalmol Vis Sci; 2020 May; 61(5):1. PubMed ID: 32392309
[TBL] [Abstract][Full Text] [Related]
18. Revisiting the binding kinetics and inhibitory potency of cardiac glycosides on Na
Noël F; Azalim P; do Monte FM; Quintas LEM; Katz A; Karlish SJD
J Pharmacol Toxicol Methods; 2018; 94(Pt 2):64-72. PubMed ID: 30244071
[TBL] [Abstract][Full Text] [Related]
19. Kinetic analysis of ouabain binding to native and mutated forms of Na,K-ATPase and identification of a new region involved in cardiac glycoside interactions.
Schultheis PJ; Wallick ET; Lingrel JB
J Biol Chem; 1993 Oct; 268(30):22686-94. PubMed ID: 8226778
[TBL] [Abstract][Full Text] [Related]
20. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides.
Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT
J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
